Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.40    0.20 (0.26%)
Bid:
78.50
Ask:
78.75
Spread: 0.25 (0.318%)
Market Cap: £1.50b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

7 Nov 2025 07:00

RNS Number : 5754G
Coats Group PLC
07 November 2025
 

 

 

 

7 November 2025

Coats Group plc

Full year in line with expectations, resilient trading, good strategic progress

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four-month period 1 July to 31 October 2025 ('the period').

 

All the following references are at Constant Exchange Rates (CER) unless specified.

 

Group Performance

 

Market conditions in the period remained subdued, with continued caution in customer ordering patterns as a result of sustained macroeconomic and tariff uncertainty. Against this backdrop, the Group delivered a resilient performance, in line with our expectations.

 

Group revenue in the period was down 1%. We saw encouraging growth in target organic adjacencies as well as further outperformance in core markets. We have also successfully managed pricing pressures and flexed our cost base in the period. As a result operating profit was at a similar level to the same period last year, with margins consistent with H1 2025 and improved from prior year, in line with our Group medium term margin target of 19-21%.

 

Cash generation has remained strong. As anticipated, leverage increased due to the completion of the OrthoLite acquisition at the end of October. We expect year-end leverage to be c.2.2x, consistent with previous guidance, and leverage to fall below 2x by the end of 2026 given the sustained improvement in cash generation.

 

Divisional Performance

 

Apparel

 

Apparel delivered a robust performance in the period with revenue 2% below the prior year period due to challenging end markets. A focus on excellent service and operational agility enabled us to outperform and win share with major brands alongside good growth in China domestic. The division maintained operating margins at c.20% during the period reflecting pricing discipline and favourable mix with customers valuing our premium and sustainable thread offerings.

 

Footwear

 

Footwear revenue was 4% lower than the prior year period, stabilising at similar run rates to Q2, a reflection of cautious customer ordering patterns given the ongoing market uncertainty. As expected, operating margin increased during the period, driven by operational initiatives implemented in the past year and an effective pricing strategy. As a result operating profit was in line with the same period last year.

 

OrthoLite, prior to completion, has continued to perform well, delivering strong revenue growth and maintaining high operating margins. We remain excited about the potential of this high-quality, margin accretive business, which will enable us to expand into the growing open cell insole segment of the footwear market.

 

Performance Materials

 

Performance Materials continued to deliver an improving performance. As expected, there was a return to growth in the period with revenue increasing 4% compared to the prior year, driven by accelerated growth in two target adjacencies, safety fabrics and energy tapes, alongside market share gains in automotive thread which offset softness in Telecom end markets. Operating margins for the period were significantly ahead of prior year reflecting the benefit of operational improvements across the division.

 

Divisional Structure Change

 

On 30 October the Group announced that it has streamlined its organisation structure into two divisions: Apparel and Footwear, to reflect the transformation of the Group's profile following the exit from the North America Yarns business and the acquisition of OrthoLite. This change reduces internal complexity and aligns the divisions more closely with the underlying textile engineering and polymer science technologies. Coats' external reporting will align to this new structure with effect from the next financial year, the year ending December 2026.

 

Outlook

 

Given the resilient performance year to date, the Group's full year outlook remains unchanged, with trading performance in line with market expectations.

 

The acquisition of market-leading OrthoLite and the portfolio rationalisation actions now taken have improved the quality of the Group. As a result we are on track to continue our outperformance of underlying market growth supported by expansion into target adjacencies and deliver strong cash generation and further margin progression in the medium term. Our confidence is underpinned by our unrivalled global footprint, proprietary technology and sustainability led innovation.

 

The Group will release its Full Year 2025 results on 5 March 2026. An updated financial framework will be provided at the March results.

 

Enquiries

Coats Group plc (Investors)

Chris Dyett

 

FTI (Communications)

Nick Hasell

Victoria Hayns

 

Tel: +44 (0) 797 497 4690

Tel: +44 (0) 20 3727 1340

 

 

About Coats Group plc

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2024, we generated $1.5 billion in revenue and employed 16,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

 

Cautionary statement

Certain statements in this full year report are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKABQOBDDNDK
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.